statistiche ricercatore

Continente	#
EU - Europa	606
NA - Nord America	584
AS - Asia	468
SA - Sud America	42
AF - Africa	18
OC - Oceania	5
Continente sconosciuto - Info sul continente non disponibili	2
Totale	1.725

Nazione	#
US - Stati Uniti d'America	571
CN - Cina	195
IT - Italia	168
GB - Regno Unito	119
SG - Singapore	110
DE - Germania	104
SE - Svezia	52
HK - Hong Kong	48
BR - Brasile	34
RU - Federazione Russa	31
FR - Francia	28
IN - India	27
NL - Olanda	26
FI - Finlandia	19
JP - Giappone	16
IE - Irlanda	15
CI - Costa d'Avorio	14
ID - Indonesia	12
PL - Polonia	12
VN - Vietnam	12
CA - Canada	11
BE - Belgio	10
TR - Turchia	10
KR - Corea	9
TW - Taiwan	7
PH - Filippine	6
AU - Australia	5
AT - Austria	4
BD - Bangladesh	3
CH - Svizzera	3
CL - Cile	3
ES - Italia	3
UA - Ucraina	3
AP - ???statistics.table.value.countryCode.AP???	2
CO - Colombia	2
EC - Ecuador	2
GR - Grecia	2
HU - Ungheria	2
IQ - Iraq	2
LT - Lituania	2
TH - Thailandia	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BB - Barbados	1
HR - Croazia	1
IL - Israele	1
IR - Iran	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
MA - Marocco	1
MG - Madagascar	1
MX - Messico	1
NG - Nigeria	1
PE - Perù	1
RO - Romania	1
SA - Arabia Saudita	1
ZA - Sudafrica	1
Totale	1.725

Nome	#
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET)	431
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients	271
Current and Emerging Treatment Options for Patients with Relapsed Myeloma	244
Choosing treatment options for patients with relapsed/refractory multiple myeloma	146
Clinicopathological and immunohistochemical characteristics in male breast cancer: a retrospective case series	142
Immunotherapeutic early-phase clinical trials and malignant gliomas : A single-center experience and comprehensive immunophenotyping of circulating leukocytes	136
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1	135
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety : a multicenter Italian retrospective study	125
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors	109
Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience	50
Totale	1.789

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	98	0	0	0	0	5	3	3	12	8	10	24	33
2021/2022	292	35	33	16	17	17	19	21	30	36	20	11	37
2022/2023	199	24	28	22	20	17	32	2	7	23	5	13	6
2023/2024	182	2	9	11	8	45	6	16	22	5	12	22	24
2024/2025	384	14	32	11	52	20	20	12	41	20	34	42	86
2025/2026	322	79	60	106	62	15	0	0	0	0	0	0	0
Totale													1.789

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca